Factors associated with mortality after breast cancer metastasis

Cancer Causes and Control

Volumn 23, Issue 1, 2012, Pages 103-112

  Jung, Su Yon ^a   Rosenzweig, Margaret ^b,c   Sereika, Susan M ^a,c   Linkov, Faina ^d   Brufsky, Adam ^b,e   Weissfeld, Joel L ^a,b,e  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Advanced breast cancer; Comorbidity; Prognostic factors

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BODY MASS; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; CANCER MORTALITY; CANCER SURVIVAL; FEMALE; HUMAN; HYPERTENSION; LIVER METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; PENNSYLVANIA; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 82955187688     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-011-9859-8     Document Type: Article

References (48)

1. Surveillance Epidemiology and End Results Program (SEER). SEER Stat Database: SEER Stat Fact Sheets; 2008
2. PA Wingo T Tong S Bolden 1995 Cancer statistics CA Cancer J Clin 45 1 8 30 7528632 10.3322/canjclin.45.1.8 1:STN:280:DyaK2M7gtlektA%3D%3D
3. Henderson IC, Harris JR, Kinne DW (1989) Cancer of the breast. In: De Vita VT, Hellman S, Rosenberg SA (eds) Cancer principles & practice of oncology, 3rd edn. Lippincott, Philadelphia, pp 1197-1268
4. J Chang GM Clark DC Allred S Mohsin G Chamness RM Elledge 2003 Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor Cancer 97 3 545 553 12548595 10.1002/cncr.11083 (Pubitemid 36125831)
5. R Largillier JM Ferrero J Doyen, et al. 2008 Prognostic factors in 1, 038 women with metastatic breast cancer Ann Oncol 19 12 2012 2019 18641006 10.1093/annonc/mdn424 1:STN:280:DC%2BD1cjlsFegtQ%3D%3D
6. S Beslija J Bonneterre HJ Burstein, et al. 2009 Third consensus on medical treatment of metastatic breast cancer Ann Oncol 20 11 1771 1785 19608616 10.1093/annonc/mdp261 1:STN:280:DC%2BD1MjhvVCmtg%3D%3D
7. MD Vincent TJ Powles R Skeet, et al. 1986 An analysis of possible prognostic features of long term and short term survivors of metastatic breast cancer Eur J Cancer Clin Oncol 22 9 1059 1065 3780813 10.1016/0277-5379(86) 90006-4 1:STN:280:DyaL2s%2FlsVWmtA%3D%3D (Pubitemid 16017140)
8. GN Hortobagyi TL Smith SS Legha, et al. 1983 Multivariate analysis of prognostic factors in metastatic breast cancer J Clin Oncol 1 12 776 786 6668494 1:STN:280:DyaL2c7jslOksA%3D%3D (Pubitemid 14167252)
9. C Cluze M Colonna L Remontet, et al. 2009 Analysis of the effect of age on the prognosis of breast cancer Breast Cancer Res Treat 117 1 121 129 18931908 10.1007/s10549-008-0222-z 1:CAS:528:DC%2BD1MXpvFyiurg%3D
10. AM Grau A Ata L Foster, et al. 2005 Effect of race on long-term survival of breast cancer patients: transinstitutional analysis from an inner city hospital and university medical center Am Surg 71 2 164 170 16022018 (Pubitemid 41725317)
11. CJ Bradley CW Given C Roberts 2002 Race, socioeconomic status, and breast cancer treatment and survival J Natl Cancer Inst 94 7 490 496 11929949 (Pubitemid 34411287)
12. M Lagerlund R Bellocco P Karlsson G Tejler M Lambe 2005 Socio-economic factors and breast cancer survival-a population-based cohort study (Sweden) Cancer Causes Control 16 4 419 430 15953984 10.1007/s10552-004-6255-7 (Pubitemid 40897833)
13. SO Dalton M During L Ross, et al. 2006 The relation between socioeconomic and demographic factors and tumour stage in women diagnosed with breast cancer in Denmark, 1983-1999 Br J Cancer 95 5 653 659 16909141 10.1038/sj.bjc.6603294 1:STN:280:DC%2BD28rhs1Squw%3D%3D (Pubitemid 44325908)
14. A Rezaianzadeh J Peacock D Reidpath A Talei SV Hosseini D Mehrabani 2009 Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran BMC Cancer 9 168 19497131 10.1186/1471-2407-9-168
15. C Bouchardy HM Verkooijen G Fioretta 2006 Social class is an important and independent prognostic factor of breast cancer mortality Int J Cancer 119 5 1145 1151 16557599 10.1002/ijc.21889 1:CAS:528:DC%2BD28Xns1Cmsbw%3D (Pubitemid 44116924)
16. MH Tao XO Shu ZX Ruan YT Gao W Zheng 2006 Association of overweight with breast cancer survival Am J Epidemiol 163 2 101 107 16339054 10.1093/aje/kwj017 (Pubitemid 43068978)
17. BJ Caan ML Kwan G Hartzell, et al. 2008 Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer Cancer Causes Control 19 10 1319 1328 18752034 10.1007/s10552-008-9203-0
18. G Berclaz S Li KN Price, et al. 2004 Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience Ann Oncol 15 6 875 884 15151943 10.1093/annonc/mdh222 1:STN:280:DC%2BD2c3lt1yqtw%3D%3D (Pubitemid 39004342)
19. S Loi RL Milne ML Friedlander, et al. 2005 Obesity and outcomes in premenopausal and postmenopausal breast cancer Cancer Epidemiol Biomarkers Prev 14 7 1686 1691 16030102 10.1158/1055-9965.EPI-05-0042 (Pubitemid 40995080)
20. MK Whiteman SD Hillis KM Curtis JA McDonald PA Wingo PA Marchbanks 2005 Body mass and mortality after breast cancer diagnosis Cancer Epidemiol Biomarkers Prev 14 8 2009 2014 16103453 10.1158/1055-9965.EPI-05-0106 (Pubitemid 41161216)
21. DW West WA Satariano DR Ragland RA Hiatt 1996 Comorbidity and breast cancer survival: a comparison between black and white women Ann Epidemiol 6 5 413 419 8915472 10.1016/S1047-2797(96)00096-8 1:STN:280:DyaK2s%2Fnt1OjtQ%3D%3D (Pubitemid 26372529)
22. G Nagel U Wedding B Rohrig D Katenkamp 2004 The impact of comorbidity on the survival of postmenopausal women with breast cancer J Cancer Res Clin Oncol 130 11 664 670 15300426 10.1007/s00432-004-0594-3 1:STN:280: DC%2BD2MzgvFOqsg%3D%3D (Pubitemid 39506380)
23. DP Cronin-Fenton M Norgaard J Jacobsen, et al. 2007 Comorbidity and survival of Danish breast cancer patients from 1995 to 2005 Br J Cancer 96 9 1462 1468 17406360 1:STN:280:DC%2BD2s3mt1Ogtg%3D%3D (Pubitemid 46685783)
24. NH Gordon P Silverman W Lasheen J Meinert LA Siminoff 2007 Thirty-year follow-up of chemo/hormonal therapy in node-positive breast cancer Breast Cancer Res Treat 102 3 301 312 17033926 10.1007/s10549-006-9338-1 1:STN:280: DC%2BD2s7nvV2qsw%3D%3D (Pubitemid 46474843)
25. D Braithwaite CM Tammemagi DH Moore, et al. 2009 Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients Int J Cancer 124 5 1213 1219 19058216 10.1002/ijc.24054 1:CAS:528:DC%2BD1MXhvFClt70%3D
26. TP Ahern TL Lash SS Thwin RA Silliman 2009 Impact of acquired comorbidities on all-cause mortality rates among older breast cancer survivors Med Care 47 1 73 79 19106734 10.1097/MLR.0b013e318180913c
27. J Ruiterkamp MF Ernst LV van de Poll-Franse K Bosscha VC Tjan-Heijnen AC Voogd 2009 Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis Eur J Surg Oncol 35 11 1146 1151 19398188 10.1016/j.ejso.2009.03.012 1:STN:280:DC%2BD1MnptlSktw%3D%3D
28. Census 2000 summary file 3 (SF 3): U.S. Census Bureau; 2000
29. American Heart Association. What Is High Blood Pressure? http://www.americanheart.org/presenter.jhtml?identifier=2114. Accessed August 1, 2009
30. ME Charlson P Pompei KL Ales CR MacKenzie 1987 A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 5 373 383 3558716 10.1016/0021-9681(87)90171-8 1:STN:280:DyaL2s7ms1GnsQ%3D%3D (Pubitemid 17055592)
31. RA Deyo DC Cherkin MA Ciol 1992 Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 6 613 619 1607900 10.1016/0895-4356(92)90133-8 1:STN:280:DyaK38zgtVeqsA%3D%3D
32. AP Dempster NM Laird DB Rubin 1977 Maximum likelihood from incomplete data via the EM algorithm J R Stat Soc Ser B (Methodological) 39 1 1 38
33. Hosmer DW Jr, Lemeshow S (1999) Applied survival analysis. Wiley Interscience, London
34. KD Swenerton SS Legha T Smith, et al. 1979 Prognostic factors in metastatic breast cancer treated with combination chemotherapy Cancer Res 39 5 1552 1562 427797 1:STN:280:DyaE1M7ks1ynuw%3D%3D (Pubitemid 9172673)
35. G Falkson R Gelman CI Falkson J Glick J Harris 1991 Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study J Clin Oncol 9 12 2153 2161 1960558 1:STN:280:DyaK38%2FntFOmsw%3D%3D
36. A Insa A Lluch F Prosper I Marugan A Martinez-Agullo J Garcia-Conde 1999 Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients Breast Cancer Res Treat 56 1 67 78 10517344 10.1023/A:1006285726561 1:STN:280:DyaK1MvksV2gsA%3D%3D (Pubitemid 29435816)
37. SJ Cutler JA Ardyce SG Taylor III 1969 Classification of patients with disseminated cancer of the breast Cancer 24 5 861 869 5353943 10.1002/1097-0142(196911)24:5<861::AID-CNCR2820240502>3.0.CO;2-3 1:STN:280:DyaE3c%2FjvF2ksg%3D%3D
38. M Ryberg D Nielsen K Osterlind T Skovsgaard P Dombernowsky 2001 Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy Ann Oncol 12 1 81 87 11249054 10.1023/A:1008384019411 1:STN:280:DC%2BD3Mzit1OisA%3D%3D (Pubitemid 32162451)
39. M Robain JY Pierga M Jouve, et al. 2000 Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer Eur J Cancer 36 18 2301 2312 11094303 10.1016/S0959-8049(00)00325-7 1:CAS:528:DC%2BD3cXotlCgsrg%3D
40. F Andre K Slimane T Bachelot, et al. 2004 Breast cancer with synchronous metastases: trends in survival during a 14-year period J Clin Oncol 22 16 3302 3308 15310773 10.1200/JCO.2004.08.095 (Pubitemid 41103686)
41. N Yamamoto T Watanabe N Katsumata, et al. 1998 Construction and validation of a practical prognostic index for patients with metastatic breast cancer J Clin Oncol 16 7 2401 2408 9667257 1:STN:280:DyaK1czivFygsw%3D%3D (Pubitemid 28309034)
42. CL Vogel S Azevedo S Hilsenbeck DR East J Ayub 1992 Survival after first recurrence of breast cancer The Miami experience Cancer 70 1 129 135 1606535 10.1002/1097-0142(19920701)70:1<129::AID-CNCR2820700122>3.0.CO;2-Y 1:STN:280:DyaK383pvVartA%3D%3D
43. EF Solomayer IJ Diel GC Meyberg C Gollan G Bastert 2000 Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis Breast Cancer Res Treat 59 3 271 278 10832597 10.1023/A:1006308619659 1:STN:280:DC%2BD3cvjt12qtg%3D%3D (Pubitemid 30243049)
44. A Goldhirsch RD Gelber M Castiglione 1988 Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses J Clin Oncol 6 1 89 97 3275752 1:STN:280:DyaL1c%2FovFyjtA%3D%3D (Pubitemid 18039996)
45. Hortobagyi GN, Kau S-W, Buzdar AU, et al. (2004) What is the prognosis of patients with operable breast cancer (BC) five years after diagnosis? [Abstract]. J Clin Oncol, In: ASCO annual meeting proceedings (Post-Meeting Edition), vol 22(14S, July 15 Supplement), p 585
46. C Grasic-Kuhar M Bracko B Zakotnik 2008 Risk factors for late relapse and death in patients with early breast cancer Neoplasma 55 5 416 420 18665752 1:STN:280:DC%2BD1cvosFGrtw%3D%3D
47. EBCTCG (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687-1717
48. P Hamet 1996 Cancer and hypertension. An unresolved issue Hypertension 28 3 321 324 8794810 1:STN:280:DyaK28zoslaktw%3D%3D